Bench, bedside, boardroom: negotiating translational gene therapy
This article presents ethnographic material from a London-based group of gene therapists who received the opportunity to trial a device that, its makers claimed, would expedite and improve their cell work. The Vanguard cell processor elicits both enthusiasm and ambivalence from group members, which...
Main Author: | Courtney Addison |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2017-01-01
|
Series: | New Genetics and Society |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/14636778.2017.1289468 |
Similar Items
-
Bench-to-bedside: Translational development landscape of biotechnology in healthcare
by: Caizhi Liao, et al.
Published: (2023-06-01) -
Gene Therapy for Inherited Retinal Diseases: From Laboratory Bench to Patient Bedside and Beyond
by: Anand Singh Brar, et al.
Published: (2023-12-01) -
Translational Antidote Research: A Bedside to Bench Tale
by: Jeffrey Brent
Published: (2015-03-01) -
Editorial: Combination Therapy for Hypothyroidism: The Journey From Bench to Bedside
by: Jacqueline Jonklaas, et al.
Published: (2020-06-01) -
Stem Cell Theory of Cancer: Implications for Translational Research from Bedside to Bench
by: Shi-Ming Tu, et al.
Published: (2022-07-01)